EKF Diagnostics Projects Strong Growth in 2024
Company Announcements

EKF Diagnostics Projects Strong Growth in 2024

EKF Diagnostics Holdings (GB:EKF) has released an update.

EKF Diagnostics Holdings PLC reports a strong start to 2024 with its Q1 performance in line with expectations and a sharp 20% increase in adjusted EBITDA compared to Q1 2023. The company highlights significant growth in high margin product lines and services, such as a 156% year-on-year increase in fermentation services and a 7% rise in β-HB sales. With an improved net cash position and continued focus on profitability, EKF projects a year of significant momentum for EBITDA margins and cash generation.

For further insights into GB:EKF stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskEKF Diagnostics Boasts Strong Mid-Year Financials
TipRanks UK Auto-Generated NewsdeskEKF Diagnostics Announces Upcoming Interim Results
TipRanks UK Auto-Generated NewsdeskEKF Diagnostics Boasts Strong Mid-Year Financials
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App